First independent assessment of pharmaceutical company action on AMR. Pharmaceutical companies have a long way to go to combat antimicrobial resistance, but a new ranking aims to hold them accountable. The Benchmark found that nine of the 19 companies reporting such efforts are running or supporting 19 AMR surveillance programmes across 147 countries.